Hemanext

Lexington, MA · Founded 2000 · Privately Held (backing)

Developer of transfusion medical technology designed to support the transfusion medicine community in efforts to save lives and improve patient outcomes. Hemanext is based in Lexington, MA and was founded in 2000. Its last reported valuation was $115 million in Oct 2024. It has raised $220 million across 6 recorded rounds; the latest was a $20 million early-stage round in Jul 2025.

Last reported valuation
$115.0M
Oct 2026
Priced at
—
Total raised
$220.3M
Last round
Early Stage VC
Jul 2025

Who backs Hemanext?

12 investors
InvestorType
Eduardo Avayu Family OfficeFamily office
Grabe Family OfficeFamily office
Omega AdvisorsHedge fund
Testa Family OfficeFamily office
Antaeus Enterprises—
David Herman—
Lung—
National Heart—
Stephen Eckert—
U.S. Department of Health and Human Services—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Hemanext investors

12 investors are on record for Hemanext, including Eduardo Avayu Family Office, Grabe Family Office, Omega Advisors and Testa Family Office. The early-stage round in Jul 2025 drew 29 investors.

Free account
More of Hemanext with a free account
  • ·The complete investor list: 12 names
  • ·Watch Hemanext: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Hemanext. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View